Unknown

Dataset Information

0

ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic.


ABSTRACT: The International Lymphoma Radiation Oncology Group (ILROG) guidelines for using radiation therapy (RT) in hematological malignancies are widely used in many countries. The emergency situation created by the COVID-19 pandemic may result in limitations of treatment resources. Furthermore, in recognition of the need to also reduce the exposure of patients and staff to potential infection with COVID-19, the ILROG task force has made recommendations for alternative radiation treatment schemes. The emphasis is on maintaining clinical efficacy and safety by increasing the dose per fraction while reducing the number of daily treatments. The guidance is informed by adhering to acceptable radiobiological parameters and clinical tolerability. The options for delaying or omitting RT in some hematological categories are also discussed.

SUBMITTER: Yahalom J 

PROVIDER: S-EPMC7243146 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic.

Yahalom Joachim J   Dabaja Bouthaina Shbib BS   Ricardi Umberto U   Ng Andrea A   Mikhaeel N George NG   Vogelius Ivan R IR   Illidge Tim T   Qi Shunan S   Wirth Andrew A   Specht Lena L  

Blood 20200501 21


The International Lymphoma Radiation Oncology Group (ILROG) guidelines for using radiation therapy (RT) in hematological malignancies are widely used in many countries. The emergency situation created by the COVID-19 pandemic may result in limitations of treatment resources. Furthermore, in recognition of the need to also reduce the exposure of patients and staff to potential infection with COVID-19, the ILROG task force has made recommendations for alternative radiation treatment schemes. The e  ...[more]

Similar Datasets

| S-EPMC10734871 | biostudies-literature
| S-BSST1055 | biostudies-other
| 2346925 | ecrin-mdr-crc
| S-EPMC7319915 | biostudies-literature
| S-EPMC8763333 | biostudies-literature
| S-EPMC7476435 | biostudies-literature
| S-EPMC7673895 | biostudies-literature
| S-EPMC7771795 | biostudies-literature
| S-EPMC8858709 | biostudies-literature
| S-EPMC10167757 | biostudies-literature